CN104983769A

CN104983769A - Medicine for treating epifolliculitis

Info

Publication number: CN104983769A
Application number: CN201510376951.3A
Authority: CN
Inventors: 包玲丽
Original assignee: Individual
Current assignee: Individual
Priority date: 2015-07-01
Filing date: 2015-07-01
Publication date: 2015-10-21

Abstract

The invention relates to a medicine for treating epifolliculitis. The medicine is prepared from the following crude drugs in weight proportion: 15 parts of taraxacum mongolicum, 10 parts of folium isatidis, 9 parts of cortex pseudolaricis and 12 parts of periostracum cicada. The inventor considers that epifolliculitis falls under the categories of hairline boils, furunculosis of buttock and wind-type malnutrition in traditional Chinese medical science and is mostly caused by retention of damp-heat in the interior, exogenous pathogenic toxin, and depression and stagnation in the skin caused by heat and dampness intersection. The treatment principle aims at clearing away heat and drying dampness, purging fire for removing toxin and killing parasites to relieve itching. In the formula, taraxacum mongolicum and folium isatidis have the effects of clearing heat and purging fire for removing toxin; cortex pseudolaricis has the effects of clearing away heat and drying dampness and killing parasites to relieve itching; periostracum cicada has the effects of dispelling wind and arresting itching. Through the combination of the crude drugs, the efficacies of clearing away heat and toxic materials and killing parasites to relieve itching are achieved. Modern pharmacological research results show that the crude drugs have higher broad-spectrum antifungal effects, and also have the effects of diminishing inflammation, astringing dampness, protecting the epidermis and promoting healing and the like. Clinical experiment results point out that the medicine can be safely and effectively applied to treatment for epifolliculitis.

Description

A kind of medicine being used for the treatment of folliculitis

Technical field

The present invention relates to a kind of medicine, be specifically related to a kind of Chinese medicine being used for the treatment of folliculitis.

Background technology

This disease is whole hair follicle bacteriological infection generation suppurative inflammation.From the beginning of being red papules, developing into papular pustule gradually, isolating and being dispersed in, conscious mild pain.Mainly betide the position of hirsutism adult, be then apt to occur in head children's, its erythra can merge mutually sometimes, can leave strip alopecia speckle more.

Pathogen is staphylococcus mainly, sometimes also separable go out staphylococcus epidermidis.Unclean, to scratch and Abwehrkraft des Koepers lowly can be the inducement of primary disease.

From the beginning of for the red lex primaria pimple consistent with follicular orifice or by pityriasis rubra impetigo, develop rapidly later and develop into papular pustule, hair is run through in centre, and surrounding blush has inflammation, then dry incrustation, about de-and heal through 1 week crust, but also have recurrent exerbation, do not heal for many years, have also can develop into deeply infection, form furuncle, carbuncle etc., generally do not stay cicatrix.Erythra number is more, isolates and is dispersed in, conscious mild pain.Mainly betide the position of hirsutism adult, be then apt to occur in head children's, its erythra can merge mutually sometimes, can leave strip alopecia speckle more.

Medical material involved in the present invention is all recorded in " China's book on Chinese herbal medicine ".

Summary of the invention

The present invention aims to provide a kind of medicine being used for the treatment of folliculitis, by selecting suitable medical material and proportioning thereof, reaches the safe and effective object being applied to folliculitis treatment.

In order to achieve the above object, the present invention is by the following technical solutions:

Be used for the treatment of a medicine for folliculitis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Herba Taraxaci 15 parts, Folium Isatidis 10 parts, Cortex Pseudolaricis 9 parts, Periostracum Cicadae 12 parts.

Inventor thinks that folliculitis belongs to the category such as " sores on the hairline ", " furunculosis of the buttock ", " malnutrition due to wind " of Chinese medicine.Many because of retention of damp-heat in the interior, diseases caused by exogenous pathogenic factor poison is evil, and Shi Re Bing Pian intersects, and strongly fragrantly falls ill in skin.Control suitable heat clearing and damp drying, eliminating fire and detoxication, killing parasites for relieving itching.Herba Taraxaci, the removing toxic substances of Folium Isatidis clearing away heat-fire in we; Cortex Pseudolaricis, heat clearing and damp drying, killing parasites for relieving itching; Periostracum Cicadae, dispelling wind for relieving itching.All medicines share, and play effect of heat-clearing and toxic substances removing, killing parasites for relieving itching altogether.Modern pharmacological research shows, above all medical instruments have stronger broad-spectrum antifungal effect, and has antiinflammatory, holds back wet, protection epidermis, promotes the effect such as healing.

Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:

1, clinical data

1.1 physical data

Inventor collects folliculitis patient 110 example in November ,-2013 in May, 2013, is divided into 2 groups at random.Treatment group 55 example, man 30 example, female 25 example, age 18-65 year, 25.0 years old mean age, the course of disease 5 days-2 years; Matched group 55 example, man 28 example, female 27 example, age 18-62 year, 22 years old mean age, the course of disease 7 days-2 years.There is not significant significant difference in two groups of Genders, age, course of disease aspects, has comparability.

1.2 inclusion criteria

There is consistent red lex primaria pimple or pityriasis rubra impetigo in the follicular orifice of scalp, upper breast, back, buttocks, surrounding blush has inflammation, has no wire hypha body and oval spore in heaps under light microscopic.

1.3 exclusion standard

In (1) 0.5 month, once system uses antibiotic;

(2) patient suffers from hepatorenal disease;

(3) women of trimester of pregnancy or age of sucking;

(4) patient compliance is poor, can not regular further consultation on time.

2, research method

2.1 Therapeutic Method

Treatment group takes the decoct that the present invention obtains according to specific embodiment 1, and every bu morning, noon and afternoon take for three times.

Matched group externally used compound Chloramphenicol Tincture, uses to specifications.

All treat 2 weeks for two groups.

2.2 statistical method

Adopt SPSS18.0 statistics software data processing.

3, therapeutic outcome

3.1 criterion of therapeutical effect

Recovery from illness: erythra disappears completely, clinical symptom disappearance;

Effective: deflorescence more than 70%, clinical symptoms obviously alleviates;

Take a turn for the better: skin is examined and disappeared 40% ~ 70%, clinical symptom relief;

Invalid: skin examines the < 40% that disappears, clinical symptoms is without improvement or increase the weight of.

3.2 daily life dietetic care

Treatments period rule of life, does not stay up late; Avoid pungent food, thing that greasy and raw meat is sent out; Avoid tobacco and wine, and regulate feelings will, keep being emotionally stable.

Result

Through the treatment of 2 weeks, treatment group was fully recovered 45 people, effective 4 people, and take a turn for the better 4 people, invalid 2 people, and total effective rate is 96.4%; Matched group cures 23 people, effective 10 people, and take a turn for the better 10 people, invalid 12 people, and total effective rate is 78.2%.Two groups of comparitive study, treatment group total effective rate is significantly higher than matched group, P < 0.05.

Visible, the medicine that the present invention obtains can safe and effective treatment folliculitis, has good medical science promotional value.

Detailed description of the invention

In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.

Embodiment 1

Take: Herba Taraxaci 15 grams, Folium Isatidis 10 grams, Cortex Pseudolaricis 9 grams, Periostracum Cicadae 12 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.

Be used for the treatment of folliculitis.Oral, every bu morning, noon and afternoon take for three times.

Embodiment 2

Take: Herba Taraxaci 15 grams, Folium Isatidis 10 grams, Cortex Pseudolaricis 9 grams, Periostracum Cicadae 12 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.

Be used for the treatment of folliculitis.Oral, daily once.

Embodiment 3

Take: Herba Taraxaci 15 grams, Folium Isatidis 10 grams, Cortex Pseudolaricis 9 grams, Periostracum Cicadae 12 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.

Be used for the treatment of folliculitis.Oral, every bu is taken for twice sooner or later.

Claims

1. be used for the treatment of a medicine for folliculitis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Herba Taraxaci 15 parts, Folium Isatidis 10 parts, Cortex Pseudolaricis 9 parts, Periostracum Cicadae 12 parts.